Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bontemps

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1990
The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim reportA C Begg, I Hofland, L Moonen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 casesS Benhmida, R Sun, E Gherga, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 14, 2018
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective studyA Dautruche, L Belin, P Cottu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]J C Horiot, P Bontemps, A C Begg, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1990
The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim reportA C Begg, I Hofland, L Moonen, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 casesS Benhmida, R Sun, E Gherga, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 14, 2018
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective studyA Dautruche, L Belin, P Cottu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1997
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialJ C Horiot, P Bontemps, W van den Bogaert, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]J C Horiot, P Bontemps, A C Begg, et al.
The British Journal of Radiology|February 4, 2015
Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancerV Pernin, L Belin, P Cottu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Pageof 3